Interplay of ST2 downregulation and inflammatory dysregulation in hypertrophic cardiomyopathy pathogenesis
BackgroundHypertrophic Cardiomyopathy (HCM) is an inherited heart disease and the pathogenesis of HCM involves genetic mutations, hemodynamic stress, and metabolic factors, with myocardial fibrosis playing a crucial role in severe clinical events. IL-33/ST2 signaling pathway known for its roles in i...
Saved in:
| Main Authors: | Xingyu Cao, Huawei Wang, Zunsong Hu, Wenfang Ma, Peng Ding, Huang Sun, Xiying Guo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1511415/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling Clinical and Genetic Distinctions in Pure‐Apical Versus Distal‐Dominant Apical Hypertrophic Cardiomyopathy
by: Kenta Sugiura, et al.
Published: (2025-03-01) -
Myocarditis in Hypertrophic Cardiomyopathy: Incidence and Contribution to Disease Progression and Outcome
by: Yulia Lutokhina, et al.
Published: (2025-04-01) -
Evidence of Declining Mortality Trends for Hypertrophic Cardiomyopathy in the United States and the Impact of the COVID‐19 Pandemic
by: Ahmed Sayed, et al.
Published: (2025-04-01) -
Myocardial morphology in hypertrophic cardiomyopathy: the current state of the problem
by: A. A. Balabai
Published: (2019-06-01) -
Phenotype variation of hypertrophic cardiomyopathy in carriers of the p.Arg870His pathogenic variant in the MYH7 gene
by: A. N. Kucher, et al.
Published: (2022-10-01)